相关实验视频
Updated: May 6, 2026

08:43
OLIgo Mass Profiling OLIMP of Extracellular Polysaccharides
Published on: June 20, 2010
13.7K
来自Flammulina velutipes的多糖体的结构解及其降脂和免疫调节活动
Wei Jia1, Wenhan Wang1, Dongsheng Yu1
1Institute of Edible Fungi, Shanghai Academy of Agricultural Sciences, Key Laboratory of Edible Fungal Resources and Utilization (South), Ministry of Agriculture and Rural Affairs, P. R. China, National Engineering Research Center of Edible Fungi, National R&D Center for Edible Fungal Processing, Key Laboratory of Agricultural Genetics and Breeding of Shanghai, Shanghai 201403, China.
Polymers
|March 13, 2024
概括
来自Flammulina velutipes的一种新型异质多糖,FVPT1,显示出降脂和增强免疫力的效果. 这种化合物可能成为免疫和胆固醇管理的新健康产品.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 自然产品 自然产品
背景情况:
- 像Flammulina velutipes这样的是生物活性化合物的来源.
- 多聚糖是复杂的碳水化合物,具有潜在的健康益处.
- 目前正在对健康应用的新型多糖类进行研究.
研究的目的:
- 从Flammulina velutipes.净化和表征一种新型异质多糖 (FVPT1) 的新型异质多糖.
- 评估FVPT1.1的低脂和免疫调节活动.
- 探索FVPT1作为功能性健康产品的潜力.
主要方法:
- 使用磁场辅助的三相分区和凝透色谱进行净化.
- 通过单糖化合物组成,甲基化分析,红外线和NMR光谱学进行结构性表征.
- 在体内测试使用斑马鱼幼虫高脂血症模型和体内巨细胞测试.
主要成果:
- FVPT1 (~1.64 × 10^4 Da) 是由L-糖,D-银糖,D-葡萄糖和D-曼诺糖组成的.
- 实现了多糖重复单元的结构阐明.
- FVPT1在斑马鱼中显示出显著的降脂效应.
- 在巨细胞中,FVPT1增强了氧化,IL-1β和IL-1分泌.
结论:
- FVPT1是一种具有定义结构的新型异多多糖.
- FVPT1具有显著的低脂和免疫调节性质.
- FVPT1显示出发展成免疫或低脂性健康产品的前景.
相关概念视频
Cellulose and Pectic Polysaccharides
3.7K
Every plant cell has a cell wall that protects the cell, provides structural support, and gives the cell shape. Cellulose, the main structural component of the plant cell wall, makes up over 30% of plant matter. It is the most abundant organic compound on earth. Cellulose is an unbranched polysaccharide composed of linear chains of glucose molecules linked by β (1→4) glycosidic bonds.
As a cell matures, its cell wall specializes according to its type. For example, the...
As a cell matures, its cell wall specializes according to its type. For example, the...
3.7K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
958
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
958

